24.6 Down To $0.84! A Batch Of Reduced-Price Drugs Are Now Available In Pharmacies
In December 2021, the Henan Provincial Medical Insurance Bureau issued a notice on the inclusion of some retail chain pharmacies into the scope of centralized quantity procurement of drugs in our province (pilot), which clearly included a number of "six unified" medical insurance designated chain pharmacies into the scope of collective procurement, and stated that the pilot was successful and planned to include all medical insurance designated pharmacies.
The latest progress has been made.
Some drugs have been reduced in price by up to 90%
Ltd, Henan Baixin Pharmaceutical Co Ltd, Runhe 24-hour Pharmacy and other 13 designated retail pharmacy chains, a total of 132 shops, were included in the scope of the "centralised procurement" of drugs as a pilot.
The drugs on the shelves are mostly for chronic diseases, such as hypertension, diabetes, high cholesterol and other cardiovascular diseases. The average price reduction of the drugs reached more than 50%, with some drugs reduced by more than 90%. For example, amlodipine besylate, a commonly used drug for cardiovascular diseases, was reduced from RMB 24.60 to RMB 0.84 per box, and atorvastatin calcium tablets were reduced from RMB 124.36 to RMB 3.6 per box.
There were also clozodipine tablets, promethazine hydrochloride tablets, enalapril maleate tablets, levetiracetam tablets, omeprazole enteric capsules, acarbose tablets, tadalafil tablets and other drugs.
The designated pharmacies included in the sale of "centralized quantity procurement" drugs must display the unified "centralized quantity procurement drugs designated sales pharmacy" sign, set up a special area or counter for the collected drugs, and post the "centralized quantity procurement drugs" logo in a prominent place.
The district will periodically conduct a review of these fixed-point pharmacies to determine whether they have been selected. The district will regularly conduct special inspections of these designated pharmacies to ensure that the public can enjoy the benefits of "centralized quantity procurement" of medicines.

From "niche" to "universal"
In 2021, the number of pharmacies joining the pooled procurement continues to expand, and the number of pharmacies joining the pooled procurement has gone from "niche" to "popular" as regional leaders. However, in the early days of the pooling process, the prices of the pooled products showed an inversion between hospitals and pharmacies, resulting in many consumers returning to hospitals and community health centres for prescriptions.
This has also become the most direct factor for pharmacies to join the collection, the Jiangsu Provincial People's Congress, Huaian Guangji Pharmaceutical Chain Co.
"I brought a proposal to include retail pharmacies in the scope of centralized procurement with quantity, hoping that the people can buy the same quality and price of collected drugs in the pharmacies at their doorsteps as in large hospitals."
Zhu Hualin believes that the inclusion of retail pharmacies in the scope of centralized quantity procurement of drugs can be a greater range of effective realization of drug prices, effectively reduce the burden of patients' drug costs, ease the pressure of payment of medical insurance funds, so that the results of reform to benefit more people.
It is understood that previously, Jiangsu Province has issued "Jiangsu Province to promote the implementation of the state organization of centralized procurement and use of drugs to expand the regional scope of work implementation plan", the scope of implementation should include all public medical institutions in the province, to participate in the pilot expansion of military medical institutions and voluntary participation in the pilot expansion of medical insurance designated socially run medical institutions, medical insurance designated retail pharmacies.
Looking for chemical products? Let suppliers reach out to you!
2026-07-11
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Isobutyl: Properties, Uses, and Industrial Applications
-
What do pharmaceutical companies look forin the rare disease field?
-
Pros And Cons Of New Testosterone Replacement Therapy
-
What Are The Top Selling Generic Drugs In 2018?
-
China Small Molecule Innovative Drugs Industry Trends to 2022
-
FDA approves Merck's new drug Belzutifan
-
Active R&D and strong demand for innovative peptide drugs
-
Anxious drug company bosses pile on innovative drugs
-
Drug company sponsorship of academic conferences unpopular? Doctors want to clean up the academic conference environment!
-
Children's medicine 'legalization' to accelerate the layout of drug companies
Recommend Reading
-
FDA Names Veteran Oncology Regulator Pazdur as Director of Drug Review Center
-
The GLP-1 Sweet Shot in India’s Diabetic Gut
-
Sun Pharma’s Utreglutide Shows Promising Weight Loss and Liver Fat Reduction
-
Biocon Weighs Merger of Biocon Biologics to Unlock Value
-
Merck Nears Acquisition of Cidara to Strengthen Flu Prevention Arsenal
-
Supply remains generally loose, the acrylonitrile market fluctuates within a range
-
This week's caustic soda prices declined (9.22-9.26)
-
Polyester Bottle Chip Spot Price Rises on the 14th
-
September Hydrogen Peroxide Market Warms Up
-
When SWIFT Goes On-Chain: A New 24/7 Order for Cross-Border Payments